Alivus Life Sciences posts steady FY26 growth as margins surge past guidance
The company reported free cash flow of Rs. 2,590 Mn for FY26
The company reported free cash flow of Rs. 2,590 Mn for FY26
EBITDA margins expand to 31.3%
Morepen Laboratories approves hiving off of medical devices business
Subscribe To Our Newsletter & Stay Updated